TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma
Future Oncology | May 16, 2026 | Volume: 22 | Issue: 12 | Pages: 1387-1396
10.1080/14796694.2026.2663956
| PMID 42142358